Oliver Dolan's most recent trade in Korro Bio Inc. was a trade of 5,500 Common Stock done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Korro Bio Inc | Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 5,500 | 23,599 | - | 0 | Common Stock | |
| Korro Bio Inc | Oliver Dolan | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 10.83 per share. | 16 Jun 2026 | 3,383 | 18,099 | - | 10.8 | 36,638 | Common Stock |
| Korro Bio Inc | Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Korro Bio Inc | Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2025 | 21,482 | 21,482 | - | 0 | Common Stock | |
| Korro Bio Inc | Oliver Dolan | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |